AASLD: New HCV Drug Promising, Cuts Out Interferon (CME/CE)
(MedPage Today) — SAN FRANCISCO -– Treatment with an investigational hepatitis C drug allowed investigators to dispense with an old stand-by — pegylated interferon-alpha.
(MedPage Today) — SAN FRANCISCO -– Treatment with an investigational hepatitis C drug allowed investigators to dispense with an old stand-by — pegylated interferon-alpha.
Comments are closed.
All rights reserved. © UK. Site Map | Contact us | About us | Contributors | Supporters | Terms & Conditions
This site complies with the HONcode standard for trustworthy health information: verify here.